糖尿病足保肢——809例尝试及血管腔内保肢失败预测因素分析
回顾性分析809例住院糖尿病足保肢患者,96%首选血管腔内治疗,其中95%需膝下血管成形术。血管腔内组1年保肢率88%高于旁路组72%,住院费用更低。多因素分析显示终末期肾衰竭、趾压<50 mmHg、腹股沟下TASC II C/D病变及间接血管体区血运重建为腔内保肢失败的独立预测因素。
要点
- 住院糖尿病足患者中73%表现为Rutherford 6级,81%趾压<50 mmHg。
- 腔内组1年保肢率88% vs 旁路组72%(P=0.01),住院费用腔内组更低。
- 终末期肾衰竭、趾压<50 mmHg、TASC II C/D及间接血管体区重建为腔内失败预测因素。
核心结论
- 在亚洲族群住院糖尿病足患者中,多数表现为Rutherford 6级及TASC II C或D病变,需膝下血运重建。
- 腔内保肢失败的独立预测因素包括终末期肾衰竭、趾压<50 mmHg、腹股沟下TASC II C或D病变及间接血管体区血运重建。
研究设计与样本
- 回顾性研究,纳入2013年8月至2015年7月间809例住院糖尿病足保肢尝试患者。
主要发现
- 68%为男性,平均年龄65岁,73%为Rutherford 6级,27%为Rutherford 5级。
- 81%趾压<50 mmHg,64%有腹股沟下TASC II C或D病变,78%有膝下TASC II C或D病变。
- 777例(96%)首选腔内保肢,其中95%需膝下血管成形术,84%需2支或3支血管血运重建;32例(4%)接受外科旁路保肢,其中63%为血管成形术失败后的补救手术。
- 腔内组平均住院12.3天 vs 旁路组31.1天(P<0.01);1年保肢率腔内组88% vs 旁路组72%(P=0.01);1年总生存率腔内组93% vs 旁路组88%(P=0.27);平均住院费用腔内组5518新加坡元 vs 旁路组15141新加坡元(P<0.01)。
- 多因素分析显示腔内保肢失败的独立预测因素:终末期肾衰竭(OR 2.04,P=0.01)、趾压<50 mmHg(OR 2.15,P=0.01)、腹股沟下TASC II C或D病变(OR 1.99,P=0.03)、间接血管体区血运重建(OR 2.03,P=0.02)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: To review patient characteristics and outcomes of in-patient diabetic foot limb salvage and identify risk factors predicting for endovascular limb salvage failure. METHODS: Retrospective study of limb salvage attempts in 809 patients between August 2013 and July 2015. RESULTS: Sixty-eight percent of our study population were male with mean age at 65 years and 73% presented with Rutherford grade 6 critical limb ischemia, with the remaining 27% Rutherford grade 5. Eighty-one percent had toe pressures of less than 50 mm Hg, 64% had infrainguinal trans-Atlantic inter-society consensus (TASC II) C or D lesions while 78% had infrapopliteal TASC II C or D lesions. Seven hundred seventy-seven patients (96%) underwent endovascular-first approach limb salvage, with 95% requiring infrapopliteal angioplasty, with 84% of them requiring 2-vessel or 3-vessel revascularization. Thirty-two patients (4%) underwent surgical bypass limb salvage, with 63% performed as salvage procedures for failed angioplasties. The mean in-patient stay was 12.3 days within the endovascular group and 31.1 days within the bypass group (P < 0.01). One-year limb salvage was successful in 88% of endovascular group, as compared with 72% in bypass group (P = 0.01). Overall 1-year survival was 93% within the endovascular group and 88% within the bypass group (P = 0.27). The mean in-patient cost was SGD$5,518 within the endovascular group and SGD$15,141 within the bypass group (P < 0.01). Multivariate analysis showed that independent predictors for failure of endovascular limb salvage include end-stage renal failure (ESRF) (odds ratio [OR] 2.04, P = 0.01), toe pressures <50 mm Hg (OR 2.15, P = 0.01), infrainguinal TASC II patterns C or D (OR 1.99, P = 0.03), and indirect angiosome revascularization (OR 2.03, P = 0.02). CONCLUSIONS: Within our study population of Asian ethnicity, most in-patient diabetic foot peripheral arterial disease presented with Rutherford grade 6 disease, with mostly TASC II C or D lesions and required infrapopliteal revascularization. As most patients had multiple comorbidities and were poor surgical candidates, the majority underwent endovascular-first approach revascularization. Independent predictors of endovascular limb salvage failure include ESRF, toe pressures <50 mm Hg, infrainguinal TASC II patterns C or D, and indirect angiosome revascularization.
引用
- Lo ZJ, Lin Z, Pua U, et al. Diabetic Foot Limb Salvage-A Series of 809 Attempts and Predictors for Endovascular Limb Salvage Failure. Ann Vasc Surg. 2018. PMID: 29428535. doi:10.1016/j.avsg.2018.01.061
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。